1Tomer Y. Hepatitis C and interferon induced thyroiditis. Au- toimmunity,2010,34(3) : 322-326.
2Tran HA,Reeves GE,Jones TL. The natural history of interfer- on-alpha2b-induced thyroiditis and its exclusivity in a cohort of patients with chronic hepatitis C infection. QJM,2009,102 (2):117-122.
4Monzani F,Caraccio N,Dardano A,et al. Thyroid autoimmunity and dysfunction associated with type I interferon therapy. Clin Exp Med, 2004,3(4):199-210.
7El Shafie O, Hussein S, E1Awady W, et al. Graves' disease following interferon therapy for chronic hepatitis C infection. Sultan Qaboos Univ Med J, 2008, 8: 75-77.
8Andrade LJ, Atta AM, Atta ML, et al. Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy. Braz J Infect Dis, 2011, 15: 377-381.
9Menconi F, Hasham A, Tomer Y. Environmental triggers of thyroiditis: hepatitis C and interferon-a. J Endocrinol Invest, 2011, 34: 78-84.
10Boadas J, Rodriguez-Espinosa J, Enriquez J, et al. Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection. J Hepatol, 1995, 22:611-615.